/
2019 Measles Update Susan Sullivan MS, RN-BC VPD Nurse Consultant 2019 Measles Update Susan Sullivan MS, RN-BC VPD Nurse Consultant

2019 Measles Update Susan Sullivan MS, RN-BC VPD Nurse Consultant - PowerPoint Presentation

SupremeGoddess
SupremeGoddess . @SupremeGoddess
Follow
342 views
Uploaded On 2022-07-28

2019 Measles Update Susan Sullivan MS, RN-BC VPD Nurse Consultant - PPT Presentation

Justin Albertson MS VPD Epidemiologist April 2019 Objectives Discuss measles clinical presentation Review current epidemiology Discuss appropriate lab testing Describe control measures ID: 930883

days measles period rash measles days rash period clinical case health incubation lab disease infectious vpd mmr settings immune

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "2019 Measles Update Susan Sullivan MS, R..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

2019 Measles Update

Susan Sullivan MS, RN-BC VPD Nurse ConsultantJustin Albertson MS, VPD Epidemiologist

April

2019

Slide2

Objectives

Discuss measles clinical presentation Review current epidemiology

Discuss appropriate lab testing

Describe control measures

Slide3

Measles

Acute viral illness

Transmitted via airborne particles or droplets

Airborne virus can remain infectious for up to 2 hours after a case occupied that space

Incubation period: 7-21 days (average 14 days

)

Infectious period: 4 days before and after rash onsetPrevented by measles-mumps-rubella vaccine (MMR)2 doses recommended (1 dose-93%; 2 doses-97% effectiveness)1st at 12-15 months of age2nd at 4-6 years of age

Slide4

Clinical Picture

Prodrome

(typically lasts 2-4 days)

High fever (up to 105°), cough, coryza (runny nose), conjunctivitis

Koplick

spots

Rash (typically lasts 4-7 days)Begins a few days after prodromeMaculopapular (flat lesions and small, solid raised lesions)Begins on head and faceSpreads to trunk and extremitiesFades in order of appearance

Slide5

Fifth’s Disease-parvovirusHand, Foot and Mouth Disease- coxsackie virus

Roseola-human herpesvirus 6, 7Scarlet fever-strepRocky Mountain Spotted FeverRecent antibiotic useContact dermatitis

Heat rash

Recent MMR vaccination

In sexually active adults, please rule out syphilis

Other Fever/Rash Causes

Slide6

Slide7

Measles Lab Testing

PCR (NC SLPH w CD Branch approval)

Throat or nasopharyngeal swab

Urine

Collect

within 3 days

of rash onsetNC SLPH now able to perform measles PCRIgM (any commercial lab)Serum specimenCollect 3 days or later after rash onsetIn vaccinated persons, there is often a blunted and/or transient production of IgMNegative

IgM in vaccinated persons suspected of having measles should not be used to rule out the

case

Viral culture (LabCorp)

Slide8

Still common in Europe, Asia, the Pacific, and Africa

Travelers with measles continue to bring disease into U.S.Measles spreads in a community where groups of people are unvaccinated

Large majority of people who get measles are unvaccinated

https

://www.cdc.gov/measles/cases-outbreaks.html

Measles in the U.S.

Slide9

Global View

Slide10

Measles in the U.S.

https://www.cdc.gov/measles/cases-outbreaks.html

Slide11

Measles in North Carolina, 2009-2018

Slide12

Wake – Johnston County Measles Case: June 2018

Unvaccinated index case returned from vacation in France on 6/2/18Rash onset 6/10/18; infectious 6/6 to 6/14Exposed persons in 3 different healthcare settings on 5 separate visits from 4 other states and 15 counties

Over 300 contacts investigated; 2 family members infected

Genotype D8A; associated with outbreak strain in Europe

Slide13

Health Care Settings

Presumptive immunity2 valid doses MMR

Lab evidence of immunity or previous

disease

Furlough non-immune exposed staff

Slide14

The Window: Incubation period 7 to 21 days, average 14 days

6/10

Rash onset

Infectious

4

days

before & after rash onset6/66/14

6/26 - End of

incubation period

for 6/6 exposures

7/4 - End

of

incubation period

for 6/14 exposures

PEP-MMR within 3 days of exposure;

IG within 6 days of exposure

Slide15

§ 130A-145. Quarantine and isolation authority

(a) The State Health Director and a local health director are empowered to exercise quarantine and isolation authority. Quarantine and isolation authority shall be exercised only

when and so long as the public health is endangered, all other reasonable means for correcting the problem have been exhausted, and no less restrictive alternative exists.

(b) A person convicted under this section for violation of G.S. 130A-145 shall not be sentenced under Article 81B of Chapter 15A of the General Statutes but shall instead be sentenced to a term of imprisonment of no more than two years…

Slide16

1. Immune Status

Shot record, disease history?Vaccine effectivenessWaning immunity?2. Clinical Presentation

Onset date of each symptom

Classic or modified presentation?

Lab results

3. Epidemiology

What is incubation period? Infectious period?Demographics, travel, employment, activities, school, congregate settings 163 Basic VPD Questions: ICE

Slide17

ScreenImmune status

Clinical informationEpi, activities, travel, exposure historyIsolateAirborne precautions for measles2 hour timeframe even after patient leaves

Call public health immediately

Assure control measures are initiated

Arrange for appropriate testing

Begin contact investigation

3 Basic Response Steps for Healthcare Settings

Slide18

Identify infection; manage case

Define population at riskManage non-immune exposed personsVaccinate?

Exclude?

4. Obtain appropriate clinical specimens

5. Maintain surveillance

18

5 VPD Control Strategies for Public Health

Educate

!

Slide19

Most clinicians have never seen a true case of measles

Immune status, clinical presentation and epi (travel history) need to be assessed for every patient presenting in an urgent care settingMost adults do not have ready access to their shot recordsUnvaccinated returning travelers continue to be a source of measles spread in the U.S.

Lessons learned